Corrections
Abstract
On page 317 of the article "Fluphenazine Enanthate and Fluphenazine Decanoate in the Treatment of Schizophrenic Outpatients: Extrapyramidal Symptoms and Therapeutic Effect" by Guy Chouinard, M.D, M.Sc., Lawrence Annable, Dip.Stat., and Andrée Ross-Chouinard, M.D., in the March 1982 issue, the last sentence in the left-hand column should read, "Jellinek and associates (12) and Rifkin and associates (13) recently found that, contrary to previous suggestions (14,15) that prolonged antiparkinsonian administration is of questionable efficacy, a substantial proportion of chronic schizophrenic patients treated with neuroleptics reacted adversely to antiparkinsonian drug withdrawal."
The staff regrets these errors.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
